Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5199932
Max Phase: Preclinical
Molecular Formula: C56H78N16O11S2
Molecular Weight: 1215.47
Associated Items:
ID: ALA5199932
Max Phase: Preclinical
Molecular Formula: C56H78N16O11S2
Molecular Weight: 1215.47
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC1=O
Standard InChI: InChI=1S/C56H78N16O11S2/c1-6-30(2)45-52(80)68-41(47(57)75)27-84-85-28-42(64-32(4)74)49(77)70-46(31(3)73)53(81)65-38(24-35-26-60-29-63-35)48(76)66-39(22-33-14-8-7-9-15-33)54(82)71(5)43(18-12-20-61-56(58)59)50(78)67-40(23-34-25-62-37-17-11-10-16-36(34)37)55(83)72-21-13-19-44(72)51(79)69-45/h7-11,14-17,25-26,29-31,38-46,62,73H,6,12-13,18-24,27-28H2,1-5H3,(H2,57,75)(H,60,63)(H,64,74)(H,65,81)(H,66,76)(H,67,78)(H,68,80)(H,69,79)(H,70,77)(H4,58,59,61)/t30-,31+,38-,39-,40-,41-,42-,43-,44-,45-,46-/m0/s1
Standard InChI Key: SGKSNHUSKUVYHG-HCOONLMZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1215.47 | Molecular Weight (Monoisotopic): 1214.5477 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. White AM, Dellsén A, Larsson N, Kaas Q, Jansen F, Plowright AT, Knerr L, Durek T, Craik DJ.. (2022) Late-Stage Functionalization with Cysteine Staples Generates Potent and Selective Melanocortin Receptor-1 Agonists., 65 (19.0): [PMID:36167503] [10.1021/acs.jmedchem.2c00793] |
Source(1):